Outsourcing Preclinical Studies to China: Benefits and Challenges Overview
Western companies with and without operations in China have developed successful approaches to conducting preclinical trials in China. The cost savings associated with using CRO preclinical services in China are discussed in this report in the context of organizational and operational differences between CRO’s based in the West and in China. Chapter 3 provides a cost comparison and a case study comparing preclinical study cost between the US and China.
View full press release